KTTAWPasithea Therapeutics Corp.同业对比
Pasithea Therapeutics Corp. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KTTAW本股 | $90219#8 | — | 0.0x#3 | 0.2x#3 | 3130.4%#1 | -46.9%#9 | -4286.7%#5 | -41.0%#4 | — | — | — | — |
| ATXI | $1M#2 | — | 2.4x#11 | 1.0x#5 | — | 75.0%#2 | -219.6%#2 | -511.2%#12 | — | — | — | — |
| PTIX | $1M#3 | 0.5x#7 | 0.8x#10 | — | — | 138.1%#1 | — | 79.4%#1 | — | — | — | — |
| CDT | $149861#6 | 0.0x#3 | 0.0x#2 | — | — | -120.3%#10 | — | -38.0%#2 | — | — | — | — |
| BFRIW | $386161#4 | — | 0.1x#8 | 0.0x#1 | 11.7%#4 | 40.7%#5 | -27.2%#1 | -176.9%#8 | -712.4%#2 | — | -72.5%#1 | — |
| SXTPW | $216295#5 | — | 0.1x#9 | 0.2x#4 | 65.5%#3 | 7.3%#6 | -771.6%#3 | -281.7%#10 | -163.8%#1 | 6#1 | — | — |
| CINGW | $117789#7 | — | 0.0x#6 | — | — | -35.6%#8 | — | -95.7%#6 | — | — | — | — |
| ERNAW | $58930#9 | 0.0x#6 | 0.0x#7 | 0.1x#2 | 755.9%#2 | 68.4%#3 | -1601.2%#4 | -440.1%#11 | -1016.2%#3 | — | — | — |
| CDTTW | $5271#13 | 0.0x#2 | 0.0x#1 | — | — | -120.3%#10 | — | -38.0%#2 | — | — | — | — |
| ASBPW | $32259#10 | 0.0x#4 | 0.0x#5 | 5.2x#7 | — | -1768.9%#12 | -312016.9%#6 | -208.2%#9 | — | — | — | — |
| REVBW | $24697#11 | 0.0x#5 | 0.0x#4 | — | — | 40.7%#4 | — | -88.5%#5 | — | — | — | — |
| ADTX | $7588#12 | 0.0x#1 | — | 2.4x#6 | -97.6%#5 | -6.8%#7 | -612542.2%#7 | — | — | — | -100.0%#2 | — |
| AAPG | $6.5B#1 | — | 179.1x#12 | 52.1x#8 | — | — | — | -153.5%#7 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议